Host directed therapies: COVID-19 and beyond
The global spread of SARS-CoV-2 has necessitated the development of novel, safe and effective therapeutic agents against this virus to stop the pandemic, however the development of novel antivirals may take years, hence, the best alternative available, is to repurpose the existing antiviral drugs wi...
Saved in:
Main Authors: | Devavrat Tripathi (Author), Megha Sodani (Author), Pramod Kumar Gupta (Author), Savita Kulkarni (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quercetin induces proteolysis of mesenchymal marker vimentin through activation of caspase-3, and decreases cancer stem cell population in human papillary thyroid cancer cell line.
by: Devavrat Tripathi, et al.
Published: (2021) -
Host-Directed Therapies for Tuberculosis
Published: (2020) -
Repurposing Antifungals for Host-Directed Antiviral Therapy?
by: Sebastian Schloer, et al.
Published: (2022) -
Towards Host-Directed Drug Therapies for Infectious and Non-Communicable Diseases
Published: (2019) -
Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance
Published: (2020)